STOCK TITAN

Nuvve Holding Corp 10-Q Filings

NVVE OTC Link

Every 10-Q that Nuvve Holding Corp (NVVE) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow NVVE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NVVE filings page.

Rhea-AI Summary

Nuvve Holding Corp. reported higher revenue but continued large losses for the six months ended June 30, 2026. Total revenue rose to $2,619,846 from $1,245,454 a year earlier, driven mainly by product sales and services, including contributions from Japan. Operating loss narrowed to $13,292,317 from $20,383,839, and net loss attributable to common stockholders was $12,982,806, including preferred dividends and accretion.

Liquidity remains strained. Cash was only $500,877 with a $8.9 million working capital deficit and a total stockholders’ deficit of $7.5 million. Net cash used in operating activities was $9,391,540. Management states that recurring losses, significant cash burn, upcoming debt maturities of about $2.1 million, and dependence on new financing raise substantial doubt about the company’s ability to continue as a going concern. After quarter-end, a majority of holders of Fermata Energy II LLC promissory notes demanded repayment; nonpayment triggered default and an 18% default interest rate on those notes.

Rhea-AI Summary

Nuvve Holding Corp. reported first‑quarter 2026 revenue of $1.39 million, up from $0.93 million a year earlier, driven mainly by higher services and grant income. The company posted an operating loss of $5.84 million and a net loss of $5.60 million, versus a $6.88 million loss in 2025. Net loss attributable to common stockholders was $5.83 million, or $(28.96) per share on 201,488 weighted‑average shares.

At March 31 2026, total assets were $13.97 million and total liabilities $15.39 million, resulting in a Nuvve stockholders’ deficit of $0.47 million. Cash was $1.73 million (plus $0.32 million restricted), with $6.00 million used in operating activities during the quarter. All $0.96 million of debt, including senior convertible notes and Fermata promissory notes, is classified as current.

Management discloses an accumulated deficit of $202.3 million, negative working capital of $2.8 million and concludes that substantial doubt exists about the company’s ability to continue as a going concern over the next 12 months. Operations are being funded through new capital raises, including issuances and conversions of Series A convertible preferred stock and multiple warrant and convertible note financings, which introduce meaningful potential dilution for common shareholders. Revenue remains concentrated, with the top five customers providing about 69.5% of first‑quarter 2026 revenue.

Rhea-AI Summary

Nuvve Holding Corp. (NVVE) filed its Q3 2025 10‑Q, reporting total revenue of $1.60 million, down from $1.92 million a year ago. Product revenue was $0.95 million, services $0.38 million, and grants $0.27 million. The company posted an operating loss of $5.11 million and a net loss of $4.79 million for the quarter.

For the first nine months, revenue was $2.84 million versus $3.50 million last year, with $12.35 million used in operating cash flow. Cash was $0.94 million at September 30, 2025, plus $0.32 million in restricted cash. Current liabilities totaled $12.94 million, and total stockholders’ deficit was $(1.92) million.

Year to date, financing provided $13.31 million, including common stock offering proceeds and warrant exercises, while debt proceeds were offset by repayments. Shares outstanding were 22,482,750 at September 30, 2025, and 33,566,009 as of November 8, 2025, reflecting significant equity issuances and conversions.